Altimmune, Inc. 4
4 · Altimmune, Inc. · Filed Jun 8, 2017
Insider Transaction Report
Form 4
Tasker Sybil
Chief Medical Officer
Transactions
- Award
Stock Options (option to buy)
2017-06-06+40,000→ 40,000 totalExercise: $4.12Exp: 2027-06-06→ Common Stock, par value $0.0001 (40,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable in four equal annual installments commencing on the first anniversary of the date of grant.